Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Minority Interest (2016 - 2025)

Historic Minority Interest for Fortress Biotech (FBIO) over the last 11 years, with Q3 2025 value amounting to $9.3 million.

  • Fortress Biotech's Minority Interest rose 12750.47% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 12750.47%. This contributed to the annual value of -$24.4 million for FY2024, which is 1633.82% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Minority Interest is $9.3 million, which was up 12750.47% from -$6.5 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Minority Interest registered a high of $140.0 million during Q2 2021, and its lowest value of -$34.5 million during Q2 2023.
  • Its 5-year average for Minority Interest is $27.4 million, with a median of $8.3 million in 2022.
  • Its Minority Interest has fluctuated over the past 5 years, first surged by 26346.27% in 2021, then crashed by 35237.24% in 2023.
  • Fortress Biotech's Minority Interest (Quarter) stood at $117.2 million in 2021, then plummeted by 92.91% to $8.3 million in 2022, then tumbled by 352.37% to -$21.0 million in 2023, then dropped by 16.34% to -$24.4 million in 2024, then skyrocketed by 138.24% to $9.3 million in 2025.
  • Its last three reported values are $9.3 million in Q3 2025, -$6.5 million for Q2 2025, and $10.2 million during Q1 2025.